SI
BLUE

Sofinnova Investments’s bluebird bio BLUE Stock Holding History

Sofinnova Investments’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-33,641
Closed -$2.14M – 55
2023
Q1 		$2.14M Buy
+33,641
New +$3.84M 0.14% 48
2018
Q3 		– Sell
-4,275
Closed -$8.69M – 61
2018
Q2 		$8.69M Buy
+4,275
New +$9.74M 0.98% 25

Other funds holding BLUE

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Sofinnova Investments's BLUE Position: Q2 2023 in Review

Sofinnova Investments sold out of bluebird bio (BLUE) in Q2 2023, closing a stake of 33,641 shares — an estimated $2.14M sold.

Sofinnova Investments first reported a position in BLUE in Q2 2018 and held it in 2 quarters. The position peaked at $8.69M in Q2 2018. 175 funds tracked by Wall St. Rank hold BLUE as of Q2 2023.

  • Sofinnova Investments reported no remaining bluebird bio position as of Q2 2023 after selling out during the quarter.
  • Sofinnova Investments sold 33,641 bluebird bio shares in Q2 2023, an estimated $2.14M.
  • Sofinnova Investments first reported a position in bluebird bio in Q2 2018 and held it in 2 quarters.
  • Sofinnova Investments's bluebird bio position peaked at $8.69M in Q2 2018.
  • 175 funds tracked by Wall St. Rank held bluebird bio as of Q2 2023.

Based on Sofinnova Investments's 13F filing for Q2 2023, filed 14 Aug 2023.